CSL - Stammkapital

Aktienkurs
130.00
Täglich Wechseln
1.00 0.78%
Monatlich
-7.79%
Jährlich
-46.78%
Q2 Prognose
127.56




Stammkapital Veränderung Datum
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Arca Biopharma USD 48.72M 338K 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Bio Path USD 9.24M 934K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
CSL USD 482.13M 93.87M 2025-12
Curis USD 12.93M 12.87M 2025-12
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Immunic USD 8K 4K 2024-06
Infinity Pharmaceuticals USD 90K 1000 2023-06
Minerva Neurosciences USD 1000 0 2024-09
TherapeuticsMD USD 11K 0 2023-09